CEO Fired

  • Most Popular
  • Most Shared

REUTERS SHOWCASE

Rate Cut Hopes

Rate Cut Hopes

BarCap expects bigger rate cuts in India in 2013.  Full Article 

Rupee Low

Rupee Low

Rupee hits 2013 low on importer demand, weak euro  Full Article | Related Story 

Vodafone Result

Vodafone Result

Vodafone keeps Verizon payout to make up for European slump  Full Article 

Tumble Bought

Tumble Bought

Yahoo's rise in Asia offsets risk from Tumblr bet  Full Article 

Bond Business

Bond Business

RBI says foreign investors may buy inflation-linked bonds  Full Article | Related Story 

Buy, Sell or Hold?

Buy, Sell or Hold?

Confused while buying stocks? Get buy, sell or hold recommendations from VantageTrade.  Full Coverage 

Reuters India Mobile

Reuters India Mobile

Get the latest news on the go. Visit Reuters India on your mobile device.  Full Coverage 

Morgan Stanley, CLSA cut Cipla ratings on earnings

Related Topics

Stocks

   
Track BSE Sectoral Indices

Track Markets: BSE Sectoral Indices

Track and analyse performance of all BSE sectoral indices and other global indices on a single page.   Full Coverage 

Various medicine pills are seen in Ljubljana February 14, 2012. REUTERS/Srdjan Zivulovic/Files

Various medicine pills are seen in Ljubljana February 14, 2012.

Credit: Reuters/Srdjan Zivulovic/Files

MUMBAI | Thu Feb 7, 2013 9:48am IST

MUMBAI (Reuters) - Morgan Stanley and CLSA downgraded their ratings on Cipla Ltd (CIPL.NS) a day after the Indian drugmaker reported a slower-than-expected rise in its October-December net profit.

Morgan Stanley cut its ratings to "equal-weight" from "overweight", citing slower growth prospects on the back of limited niche drug launches, lower margins and a higher tax rate. The bank also cut its price target to 414 rupees from 437 rupees.

CLSA cut its ratings on Cipla to "underperform" from "outperform", citing disappointing margins in the October-December quarter and expectations near-term earnings growth will be slower due a higher base. The bank cut its price target to 415 rupees from 475 rupees.

(Reporting by Abhishek Vishnoi and Rafael Nam; Editing by Subhranshu Sahu)

Comments (0)
This discussion is now closed. We welcome comments on our articles for a limited period after their publication.